A COVID-19 briefing with experts from the Infectious Diseases Society of America:
Topical Agenda for March 25 Briefing:
- Preparing for future pandemics
- How COVID-19 vaccine development can inform future efforts
- Enduring health inequities
- Impending health threats, including antimicrobial resistance
- Questions from the media
FEATURING:
Daniel P. McQuillen, MD, FIDSA, FACP—Burlington, MA (Moderator)
President Elect—Infectious Diseases Society of America
Director, Solid Organ Transplant Infectious Disease, Beth Israel Lahey Hospital & Medical Center
Assistant Professor of Medicine, Tufts University School of Medicine
Helen Boucher, MD, FIDSA, FACP—Boston, MA
Treasurer, Board of Directors—Infectious Diseases Society of America
Chief, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center
Director, Levy Center for Integrated Management of Antimicrobial Resistance (CIMAR), Tufts Medical Center
Angélica Cifuentes Kottkamp, MD, FIDSA—New York, NY
Member, Inclusion, Diversity, Access & Equity Task Force—Infectious Diseases Society of America
Assistant Professor of Medicine, NYU Grossman School of Medicine
Director, Bellevue Site, NYU Langone Vaccine Trial & Evaluation Unit
Matthew Zahn, MD, FIDSA—Santa Ana, CA
Fellow—Infectious Diseases Society of America
Medical Director, Division of Epidemiology and Assessment, Orange County Health Care Agency
Liaison Representative, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention
